Cyclosporin effectively inhibits posterior capsule opacification after phacoemulsification in rabbits: A preliminary study

Clinical and Experimental Ophthalmology

Volumn 36, Issue 1, 2008, Pages 62-66

  Totan, Yüksel ^a   Yaǧci, Ramazan ^a,b   Erdurmuç, Mesut ^a   Bayrak, Reyhan ^a   Hepşen, Ibrahim Feyzi ^a  

^a FATIH UNIVERSITY   (Turkey)

^b Fatih University ^*  (Turkey)

Author keywords

Cyclosporin; Posterior capsule opacification; Rabbit

Indexed keywords

CYCLOSPORIN A; OFLOXACIN; PREDNISOLONE ACETATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATARACT; CELL PROLIFERATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORNEA EDEMA; DRUG INHIBITION; HISTOPATHOLOGY; LENS EPITHELIUM; NONHUMAN; PHACOEMULSIFICATION; POSTOPERATIVE COMPLICATION; RABBIT; RECURRENT DISEASE; SLIT LAMP;

ANIMALS; CATARACT; CATARACT EXTRACTION; CELL PROLIFERATION; CYCLOSPORINE; EPITHELIAL CELLS; IMMUNOSUPPRESSIVE AGENTS; LENS CAPSULE, CRYSTALLINE; PHACOEMULSIFICATION; POSTOPERATIVE PERIOD; RABBITS;

EID: 39649096533     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2007.01653.x     Document Type: Article

References (34)

1. Apple DJ, Solomon KD, Tetz MR et al. Posterior capsule opacification. Surv Ophthalmol 1992; 37: 73-116.
2. Schaumberg DA, Dana MR, Christen WG, Glynn RJ. A systematic overview of the incidence of posterior capsule opacification. Ophthalmology 1998; 105: 1213-21.
3. McDonnell PJ, Zarbin MA, Green WR. Posterior capsule opacification in pseudophakic eyes. Ophthalmology 1983; 90: 1548-53.
4. McDonnell PJ, Stark WJ, Green WR. Posterior capsule opacification: A specular microscopic study. Ophthalmology 1984; 91: 853-6.
5. Frezzotti R, Caporossi A, Mastrangelo D etal. Pathogenesis of posterior capsular opacification. Part II. Histopathological and in vitro culture findings. J Cataract Refract Surg 1990; 16: 353-60.
6. Kappelhof JP, Vrensen GF. The pathology of after-cataract. A minireview. Acta Ophthalmol Suppl 1992; 205: 13-24.
7. Nishi O, Nishi K, Wada K, Ohmoto Y, Akura J. Inhibition of lens epithelial cells by Fas-specific antibody activating Fas-Fas ligand system. Curr Eye Res 2001; 23: 192-8.
8. van Tenten Y, Schuitmaker HJ, De Groot V, Willekens B, Vrensen GF, Tassignon MJ. A preliminary study on the prevention of posterior capsule opacification by photodynamic therapy with bacteriochlorin A in rabbits. Ophthalmic Res 2002; 34: 113-8.
9. Xie L, Sun J, Yao Z. Heparin drug delivery system for prevention of posterior capsular opacification in rabbit eyes. Graefes Arch Clin Exp Ophthalmol 2003; 241: 309-13.
10. Ismail MM, Alio JL, Ruiz Moreno JM. Prevention of secondary cataract by antimitotic drugs: Experimental study. Ophthalmic Res 1996; 28: 64-9.
11. Inan UU, Ozturk F, Kaynak S et al. Prevention of posterior capsule opacification by intraoperative single-dose pharmacologic agents. J Cataract Refract Surg 2001; 27: 1079-87.
12. Nishi O. Posterior capsule opacification. Part 1: Experimental investigations. J Cataract Refract Surg 1999; 25: 106-17.
13. Ruiz JM, Medrano M, Alio JL. Inhibition of posterior capsule opacification by 5-fluorouracil in rabbits. Ophthalmic Res 1990; 22: 201-8.
14. Inan UU, Ozturk F, Kaynak S, Ilker SS, Ozer E, Guler C. Prevention of posterior capsule opacification by retinoic acid and mitomycin. Graefes Arch Clin Exp Ophthalmol 2001; 239: 693-7.
15. Hepsen IF, Bayramlar H, Gultek A, Ozen S, Tilgen F, Evereklioglu C. Caffeic acid phenethyl ester to inhibit posterior capsule opacification in rabbits. J Cataract Refract Surg 1997; 23: 1572-6.
16. Humphry RC, Davies EG, Jacob TJ, Thompson GM. The human anterior lens capsule - an attempted chemical debridement of epithelial cells by ethylenediaminetetracetic acid (EDTA) and trypsin. Br J Ophthalmol 1988; 72: 406-8.
17. Haus CM, Galand AL. Mitomycin against posterior capsular opacification: an experimental study in rabbits. Br J Ophthalmol 1996; 80: 1087-91.
18. Cortina P, Gomez-Lechon MJ, Navea A, Menezo JL, Terencio MC, Diaz-Llopis M. Diclofenac sodium and cyclosporin A inhibit human lens epithelial cell proliferation in culture. Graefes Arch Clin Exp Ophthalmol 1997; 235: 180-5.
19. Aslam TM, Devlin H, Dhillon B. Use of Nd: YAG laser capsulotomy. Surv Ophthalmol 2003; 48: 594-612.
20. Leonardi A, DeFranchis G, Fregona IA, Violato D, Plebani M, Secchi AG. Effects of cyclosporin A on human conjunctival fibroblasts. Arch Ophthalmol 2001; 119: 1512-7.
21. Tatlipinar S, Akpek EK. Topical ciclosporin in the treatment of ocular surface disorders. Br J Ophthalmol 2005; 89: 1363-7.
22. Garweg JG, Wegmann-Burns M, Goldblum D. Effects of daunorubicin, mitomycin C, azathioprine and cyclosporin A on human retinal pigmented epithelial, corneal endothelial and conjunctival cell lines. Graefes Arch Clin Exp Ophthalmol 2006; 244: 382-9.
23. Nishi O, Nishi K, Imanishi M. Synthesis of interleukin-1 and prostaglandin E2 by lens epithelial cells of human cataracts. Br J Ophthalmol 1992; 76: 338-41.
24. Nishi O, Nishi K, Fujiwara T, Shirasawa E, Ohmoto Y. Effects of the cytokines on the proliferation of and collagen synthesis by human cataract lens epithelial cells. Br J Ophthalmol 1996; 80: 63-8.
25. Won YH, Sauder DN, McKenzie RC. Cyclosporin A inhibits keratinocyte cytokine gene expression. Br J Dermatol 1994; 130: 312-9.
26. Lois N, Taylor J, McKinnon AD, Forrester JV. Posterior capsule opacification in mice. Arch Ophthalmol 2005; 123: 71-7.
27. Bresser P, Jansen HM, Weller FR, Lutter R, Out TA. T-cell activation in the lungs of patients with systemic sclerosis and its relation with pulmonary fibrosis. Chest 2001; 120: 66S-8S.
28. Shimizudani N, Murata H, Keino H etal. Conserved CDR 3 region of T cell receptor BV gene in lymphocytes from bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis. Clin Exp Immunol 2002; 129: 140-9.
29. Nishi O, Nishi K, Wada K, Ohmoto Y. Expression of transforming growth factor (TGF)-alpha, TGF-beta(2) and interleukin 8 messenger RNA in postsurgical and cultured lens epithelial cells obtained from patients with senile cataracts. Graefes Arch Clin Exp Ophthalmol 1999; 237: 806-11.
30. Wallentin N, Lundgren B, Holmen JB, Lundberg C. Development of posterior capsule opacification in the rabbit. Ophthalmic Res 2002; 34: 14-22.
31. Elgohary MA, Dowler JG. Incidence and risk factors of Nd: YAG capsulotomy after phacoemulsification in non-diabetic and diabetic patients. Clin Experiment Ophthalmol 2006; 34: 526-34.
32. Chung HS, Lim SJ, Kim HB. Effect of mitomycin-C on posterior capsule opacification in rabbit eyes. J Cataract Refract Surg 2000; 26: 1537-42.
33. Gwon AE, Gruber LJ, Mundwiler KE. A histologic study of lens regeneration in aphakic rabbits. Invest Ophthalmol Vis Sci 1990; 31: 540-7.
34. Oh C, Saville BA, Cheng YL, Rootman DS. A compartmental model for the ocular pharmacokinetics of cyclosporine in rabbits. Pharm Res 1995; 12: 433-7.